Edwards Lifesciences Corporation (EW) Institutional Ownership & Insider Trading

1,333 institutions reported holding Edwards Lifesciences Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 55 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

EWEdwards Lifesciences CorporationFollow EW — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 51.3B
P/E TTM: 51.2
Dividend yield: —
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

1,333 institutions held 91.2% of the shares. Across filers that reported both quarters, shares held changed +2.5%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	1,333	526	+2.5%	395	115	403	77
Mar 26	1,281	504	+1.6%	387	65	382	84
Dec 25	1,290	502	-5.8%	367	95	405	72
Sep 25	1,221	524	+5.6%	367	61	344	77
Jun 25	1,232	501	-1.1%	350	114	373	68
Mar 25	1,166	497	+0.6%	328	72	399	103
Dec 24	1,187	501	+1.2%	300	90	445	118
Sep 24	1,163	473	-4.7%	310	102	452	199

Edwards Lifesciences Corporation — questions

Who owns Edwards Lifesciences Corporation stock?: 1,333 institutions reported Edwards Lifesciences Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (10.2%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%), VANGUARD PORTFOLIO MANAGEMENT LLC (4.6%).
Are Edwards Lifesciences Corporation insiders buying or selling?: 55 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Edwards Lifesciences Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.